Gross-total hematoma removal of hypertensive basal ganglia hemorrhages: A long-term follow-up

Journal of the Neurological Sciences

Volumn 287, Issue 1-2, 2009, Pages 100-104

  Zuo, Yi ^a   Cheng, Gang ^a   Gao, Da Kuan ^a   Zhang, Xiang ^a   Zhen, Hai Ning ^a   Zhang, Wei ^a   Xiao, San Chao ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Cardiology   (China)

Author keywords

Gross total removal of the hematoma; Hypertensive basal ganglia hemorrhage; Sub total removal of the hematoma

Indexed keywords

6 KETO PROSTAGLANDIN F1 ALPHA; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ENDOTHELIN; PROSTAGLANDIN F1 ALPHA; STEROID; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL GANGLION HEMORRHAGE; BRAIN EDEMA; BRAIN HEMATOMA; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CRANIECTOMY; ENCEPHALITIS; FEMALE; GLASGOW COMA SCALE; HUMAN; HYPERTENSIVE BASAL GANGLIA HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS;

6-KETOPROSTAGLANDIN F1 ALPHA; AGED; BASAL GANGLIA HEMORRHAGE; BIOLOGICAL MARKERS; BRAIN EDEMA; DISEASE PROGRESSION; ENCEPHALITIS; ENDOTHELINS; FEMALE; FOLLOW-UP STUDIES; GLASGOW COMA SCALE; HUMANS; HYPERTENSION; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; THROMBOXANE B2; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350618769     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.08.046     Document Type: Article

References (34)

1. Cheung R.T. Update on medical and surgical management of intracerebral hemorrhage. Rev Recent Clin Trials 2 (2007) 174-181
2. Sessa M. Intracerebral hemorrhage and hypertension. Neurol Sci 29 Suppl 2 (2008) S258-S259
3. Flaherty M.L., Haverbusch M., Sekar P., Kissela B., Kleindorfer D., Moomaw C.J., et al. Long-term mortality after intracerebral hemorrhage. Neurology 66 8 (2006) 1182-1186
4. Vermeer S.E., Algra A., Franke C.L., Koudstaal P.J., and Rinkel G.J. Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology 59 (2002) 205-209
5. Kothari R.U., Brott T.G., Broderick J.P., Barsan W.G., Sauerbeck L.R., Zuccarello M., et al. The ABCs of measuring intracranial hemorrhage volumes. Stroke 27 (1996) 1304-1305
6. Hantson L., De Weerdt W., De Keyser J., Diener H.C., Franke C., Palm R., et al. The European Stroke Scale. Stroke 25 (1994) 2215-2219
7. van der Putten J.J., Hobart J.C., Freeman J.A., and Thompson A.J. Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel Index and the Functional Independence Measure. J Neurol Neurosurg Psychiatry 66 (1999) 480-484
8. Shah S.D., Kalita J., Misra U.K., Mandal S.K., and Srivastava M. Prognostic predictors of thalamic hemorrhage. J Clin Neurosci 12 (2005) 559-561
9. Elijovich L., Patel P.V., and Hemphill J.C. Intracerebral hemorrhage. Semin Neurol 28 (2008) 657-667
10. Davis S.M., Broderick J., Hennerici M., Brun N.C., Diringer M.N., Mayer S.A., et al. Recombinant activated factor VII intracerebral hemorrhage trial investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 66 (2006) 1175-1181
11. Qureshi A.I., Tuhrim S., Broderick J.P., Batjer H.H., Hondo H., and Hanley D.F. Spontaneous intracerebral hemorrhage. N Engl J Med 344 (2001) 1450-1460
12. Gebel J.M., Brott T.G., Sila C.A., Tomsick T.A., Jauch E., Salisbury S., et al. Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intra cerebral hemorrhage. Stroke 31 (2000) 596-600
13. Gebel J.M., Jauch E.C., Brott T.G., Khoury J., Sauerbeck L., Salisbury S., et al. Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 33 (2002) 2631-2635
14. Gebel J.M., Jauch E.C., Brott T.G., Khoury J., Sauerbeck L., Salisbury S., et al. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 33 (2002) 2636-2641
15. Qureshi A.I., Ling G.S., Khan J., Suri M.F., Miskolczi L., Guterman L.R., et al. Quantitative analysis of injured, necrotic, and apoptotic cells in a new experimental model of intracerebral hemorrhage. Crit Care Med 29 (2001) 152-157
16. Lee S.T., Chu K., Sinn D.I., Jung K.H., Kim E.H., Kim S.J., et al. Erythropoietin reduces perihematomal inflammation and cell death with enos and stat3 activations in experimental intracerebral hemorrhage. J Neurochem 96 (2006) 1728-1739
17. Hua Y., Nakamura T., Keep R.F., Wu J., Schallert T., Hoff J.T., et al. Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg 104 (2006) 305-312
18. Nakamura T., Keep R.F., Hua Y., Nagao S., Hoff J.T., and Xi G. Iron-induced oxidative brain injury after experimental intracerebral hemorrhage. Acta Neurochir Suppl 96 (2006) 194-198
19. Mantle D., Siddique S., Eddeb F., and Mendelow A.D. Comparison of protein carbonyl and antioxidant levels in brain tissue from intracerebral haemorrhage and control cases. Clin Chim Acta 312 (2001) 185-190
20. Schubert G.A., Schilling L., and Thomé C. Clazosentan, an endothelin receptor antagonist, prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage: a laser Doppler flowmetry study in rats. J Neurosurg 109 (2008) 1134-1140
21. Hutchison A.A., Ogletree M.L., Palme C.J., Leheup B.P., Barrett J.M., Fleischer A.C., et al. Plasma 6-keto prostaglandin F1 alpha and thromboxane B2 in sick preterm neonates. Prostaglandins Leukot Med 18 (1985) 163-181
22. Rodriguez R., Baena Y., Gaetani P., Grignani G., and Pacchiarini L. Effect of nimodipine on arachidonic acid metabolites after subarachnoid hemorrhage. Acta Neurol Scand 76 (1987) 267-271
23. Zheng Z., and Yenari M.A. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol Res 26 (2004) 884-892
24. Mayne M., Ni W., Yan H.J., Xue M., Johnston J.B., Del Bigio M.R., et al. Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-alpha expression is neuroprotective after intracerebral hemorrhage. Stroke 32 (2001) 240-248
25. Lee S.T., Chu K., Jung K.H., Kim S.J., Kim D.H., Kang K.M., et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 131 (2008) 616-629
26. Orakcioglu B., Becker K., Sakowitz O.W., Herweh C., Köhrmann M., Huttner H.B., et al. MRI of the perihemorrhagic zone in a rat ICH model: effect of hematoma evacuation. Neurocrit Care 8 (2008) 448-455
27. Orakcioglu B., Becker K., Sakowitz O.W., Unterberg A., and Schellinger P.D. Serial diffusion and perfusion MRI analysis of the perihemorrhagic zone in a rat ICH model. Acta Neurochir Suppl 103 (2008) 15-18
28. Nehls D.G., Mendelow D.A., Graham D.I., and Teasdale G.M. Experimental intracerebral hemorrhage: early removal of a spontaneous mass lesion improves late outcome. Neurosurgery 27 (1990) 674-682
29. Pantazis G., Tsitsopoulos P., Mihas C., Katsiva V., Stavrianos V., and Zymaris S. Early surgical treatment vs conservative management for spontaneous supratentorial intracerebral hematomas: a prospective randomized study. Surg Neurol 66 (2006) 492-501
30. Kaya R.A., Türkmenoǧlu O., Ziyal I.M., Dalkiliç T., Sahin Y., and Aydin Y. The effects on prognosis of surgical treatment of hypertensive putaminal hematomas through transsylvian transinsular approach. Surg Neurol 59 (2003) 176-183
31. Fernandes H.M., Gregson B., Siddique S., and Mendelow A.D. Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke 31 (2000) 2511-2516
32. Huang C.F., Tsai Z.P., Li C.S., Wang K.L., and Wang Y.C. Surgical improvement of brain edema related to hypertensive intracerebral hemorrhage. Zhonghua Yi Xue Za Zhi (Taipei) 65 (2002) 241-246
33. Murthy J.M., Chowdary G.V., Murthy T.V., Bhasha P.S., and Naryanan T.J. Decompressive craniectomy with clot evacuation in large hemispheric hypertensive intracerebral hemorrhage. Neurocrit Care 2 (2005) 258-262
34. Sutherland G.R., and Auer R.N. Primary intracerebral hemorrhage. J Clin Neurosci 13 (2006) 511-517